Drug – bio-affecting and body treating compositions – Whole live micro-organism – cell – or virus containing – Genetically modified micro-organism – cell – or virus
Reexamination Certificate
2005-09-20
2005-09-20
Guzo, David (Department: 1636)
Drug, bio-affecting and body treating compositions
Whole live micro-organism, cell, or virus containing
Genetically modified micro-organism, cell, or virus
C424S093100, C424S093600, C435S320100, C435S325000, C435S069100, C435S455000, C435S456000, C435S457000, C435S235100, C536S023100, C536S023720, C536S023200, C536S024100
Reexamination Certificate
active
06946126
ABSTRACT:
The present invention provides replicating [100K−] adenovirus vectors that have an impairment in 100K activity. In particular preferred embodiments, the impairment is the result of a deletion in the 100K coding region of the adenovirus vector genome. It is further preferred that the adenovirus produces the E1 gene products. In an alternate embodiment, the adenovirus produces the E1a gene products, but has an impairment in the E1b coding region, such that replication of the virus is limited to p53− cells. Also described are methods of making and administering the inventive adenovirus vectors to a cell or to a subject. Further provided is use of the inventive [100K−] Ad vectors as a helper virus for the production of vector stocks of adeno-associated virus.
REFERENCES:
patent: 6328958 (2001-12-01), Amalfitano et al.
Amalfitano Andrea
Hodges Bradley L.
Koeberl Dwight D.
Duke University
Guzo David
Myers Bigel Sibley & Sajovec P.A.
LandOfFree
Replicating adenovirus vectors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Replicating adenovirus vectors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Replicating adenovirus vectors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3442742